Skip to main content

November 18, 2020. ATLANTA – LifeQ, the world-leading independent provider of wearable-derived health information has released an innovative new blood oxygen monitoring solution.  The Xiamo Mi Smartwatch will open up the opportunity to get regulatory approvals for a variety of solutions, that require the monitoring of blood oxygen levels over time.  These include conditions where there are sudden drops in blood oxygen, such as sleep apnea as well as for other clinical issues.

Tracking COVID-19 and your health

The need for wrist worn consumer wearables to measure blood oxygen levels has been highlighted by the current global COVID-19 pandemic. The Xiamo Mi Smartwatch launch follows closely behind the release of LifeQ’s early warning and disease tracking system for COVID-19.   LifeQ’s COVID-19 solution has already proven effective. It provides early warnings up to a week prior to clinical diagnosis of COVID-19.

Need for more accurate devices

Wearable designers have faced major challenges in designing blood oxygen monitoring solutions.  Physiological signals generated by its sensors are key to accuracy.  The patented on-device solution has focussed on resolving the accuracy problem. It uses advanced signal conditioning techniques. This delivers continuous accurate biometric monitoring while maintaining the super low power performance of the device.

How does this LifeQ technology work?

The LifeQ solution uses reflected light from a sensor embedded in the back of a wrist worn smartwatch. It’s capable of measuring SpO2 either through user-initiated tests or on a continuous basis.

Solution for sleep apnea

LifeQ are confident about their product’s superior accuracy. They believe it will open up the opportunity to get regulatory approvals for conditions where there are sudden drops in blood oxygen, such as sleep apnea and other clinical issues.

LifeQ

“The incorporation of our blood oxygen measurement capabilities into the Xiaomi Mi Smart Watch is the culmination of years of research working with leading device, silicon and sensor partners across the globe,” says Laurie Olivier, CEO of LifeQ.

Captures optical paths through the skin

The Xiaomi Mi-watch uses a brand-new sensor designed by LifeQ in partnership with Texas Instruments. This sensor combines the power of the latest control chip from Texas Instruments . It also has a unique multi wavelength (colour) sensor configuration. It has been designed to enable the device to capture four separate optical paths through the skin.

Biometric signals to ensure blood oxygen levels remain healthy

These multiple paths allow the algorithms on the device to better isolate biometric signals from the environmental noise to deliver superior accuracy. At the same time limiting power consumption of the sensor. By adding the red and infrared light emitting diodes, the sensor is now able to deliver Pulse Oximetry for users.

 

blood oxygen monitoring

The watch provides incredible flexibility to wearable device companies for innovation. It uses multiple diodes, wavelengths and the power of the TI chip to deliver further improvements over the lifetime of the device.

Who is LifeQ?

Blood oxygen monitoring

Laurie Oliver, CEO of LifeQ

LifeQ is the leading independent provider of biometrics and health information derived from wearable devices, used in world-leading health management solutions.

LifeQ’s information and solutions are already used by Fortune 500 customers. The company partners in a range of wearable devices, consumer-facing health and wellness platforms, and health-risk tracking applications for the global insurance and corporate wellness industries.

Read more about technology developments in health

Read more about how to keep your brain healthy and young. Hyperbaric oxygen therapy will change the way your brain ages.

 

Em Sloane

Em Sloane

I am an introverted nature lover, and long time contributor to LongevityLive.com. My role is to publish the information in a consumer friendly format, which we receive on the latest medical news, press releases and general information on the latest longevity related research findings.

Longevity Live is a digital publisher AND DOES NOT OFFER PERSONAL HEALTH OR MEDICAL ADVICE. IF YOU’RE FACING A MEDICAL EMERGENCY, CALL YOUR LOCAL EMERGENCY SERVICES IMMEDIATELY, OR VISIT THE NEAREST EMERGENCY ROOM OR URGENT CARE CENTER. YOU SHOULD CONSULT YOUR HEALTHCARE PROVIDER BEFORE STARTING ANY NUTRITION, DIET, EXERCISE, FITNESS, MEDICAL, OR WELLNESS PROGRAM.

This content, developed through collaboration with licensed medical professionals and external contributors, including text, graphics, images, and other material contained on the website, apps, newsletter, and products (“Content”), is general in nature and for informational purposes only and does not constitute medical advice; the Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.

Longevity Live makes no guarantees about the efficacy or safety of products or treatments described in any of our posts. Any information on supplements, related services and drug information contained in our posts are subject to change and are not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

Longevity does not recommend or endorse any specific test, clinician, clinical care provider, product, procedure, opinion, service, or other information that may be mentioned on Longevity’s websites, apps, and Content.

error: Content is protected !!